ReviewFrontiers in pharmacology2026

From dopamine to muscarine: xanomeline-trospium (KarXT) as a novel direction in the psychopharmacotherapy of schizophrenia.

Kacper Żełabowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.